LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2009

Jun 2, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC./DE (LXRX)
CIK: 0001062822
Period of Report: 2009-06-02

Reporting Person: BANSAL AJAY (EVP Corp Dev and CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-06-02	Employee Stock Option (right to buy)	$1.53	A	250000	Acquired	2019-06-02	Common Stock (250000.00)	Direct

Footnotes

F1: Option vests with respect to 25% of the shares subject to the option on the first anniversary of employment (6/2/2010) and vests 1/48th for each month of service thereafter.